| Active Ingredient | SALBUTAMOL |
| Therapeutic Class | SELECTIVE BETA2 ADRENERGIC AGONIST (RESPIRATORY) |
| Indications | Bronchospasm. |
| Caution | Tachycardia, palpitations, tremor, nervousness, headache, insomnia,nausea. |
| Dose Range |
Aerosol: 1-3 puffs, 3-4 times daily. Syrup: 1 month- 2 yrs: 100 mcg/kg (max.2 mg) 3-4 times daily ; 2- 6 yrs: 1- 2 mg 3-4 times daily. s.c or i.m inj: 0.5mg repeated every 4 hours if necessary. See BDS supply protocols pg. 10 |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | IPRATROPIUM | SALBUTAMOL |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications |
Treating moderate-to-severe COPD; it is indicated primarily in patients who fail to resp ond on ipratropium alone. The role of the combination in acute asthma is unclear. |
| Caution | Tachycardia, dry mouth, Bronchitis, upper respiratory tract infections and headache. |
| Dose Range |
Two inhalations four times daily is indicated in chronic obstructive pulmonary disease. In severe acute asthma, ipratropium 0.5mg/salbutamol 2.5mg via nebulizer has been administered. See BDS supply protocols pg. 10. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |